Literature DB >> 7718855

Do beta-lactam-beta-lactamase inhibitor combinations have a place in the treatment of multidrug-resistant pulmonary tuberculosis?

W W Yew, C F Wong, J Lee, P C Wong, C H Chau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7718855     DOI： 10.1016/0962-8479(95)90588-x

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN： 0962-8479


× No keyword cloud information.
  9 in total

Review 1.  Future directions in the development of new antitubercular drugs. Where do we go from here?

Authors:  W W Yew; C H Chau
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

2.  Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra.

Authors:  C J Hackbarth; I Unsal; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 3.  Current development and future prospects in chemotherapy of tuberculosis.

Authors:  Eric L Nuermberger; Melvin K Spigelman; Wing Wai Yew
Journal:  Respirology       Date:  2010-06-04       Impact factor: 6.424

Review 4.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

5.  Imipenem for treatment of tuberculosis in mice and humans.

Authors:  Henry F Chambers; Joan Turner; Gisela F Schecter; Masae Kawamura; Philip C Hopewell
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.

Authors:  R K Voladri; D L Lakey; S H Hennigan; B E Menzies; K M Edwards; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 7.  Reappraising the use of β-lactams to treat tuberculosis.

Authors:  Sebastian G Kurz; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2012-09       Impact factor: 5.091

Review 8.  Have we realized the full potential of β-lactams for treating drug-resistant TB?

Authors:  Elizabeth Story-Roller; Gyanu Lamichhane
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

Review 9.  Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Authors:  Giovanni Sotgiu; Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Susanna Esposito; Simone Dore; Antonio Spanevello; Giovanni Battista Migliori
Journal:  Int J Mol Sci       Date:  2016-03-12       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.